Public list Medical Devices (6162)
:The company's primary goals are to eliminate unnecessary breast surgeries, find the breast cancers that are often missed, facilitate the therapy delivery process, and save the company's healthcare system $2.3 billion annually. n
Company (Alive / Active)
3371 Melendy Drive
San Carlos, 94070
California, United States
Total Funding | Date of Last Funding | |
---|---|---|
Bioluminate | $0M | Mar 22, 2021 |
See all 13 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Company | Status | Description | Investors |
---|---|---|---|
Irvine, California, United States | Acquired | SenoRx develops surgical products for breast cancer. | Login to see details |
Rockville, Maryland, United States | Alive / Active | 20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a proprietary algorithm to combine the biomarker values to generate a unitary risk score. | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Multisensor probe for tissue identification | Aug 22, 2008 | May 17, 2011 | Patent |